bioXXmed AG (XTER:T5O) Days Payable : 0.00 (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is bioXXmed AG Days Payable?

bioXXmed AG's average Accounts Payable for the six months ended in Jun. 2023 was €0.04 Mil. bioXXmed AG's Cost of Goods Sold for the six months ended in Jun. 2023 was €0.00 Mil.

The historical rank and industry rank for bioXXmed AG's Days Payable or its related term are showing as below:

During the past 13 years, bioXXmed AG's highest Days Payable was 56.52. The lowest was 35.38. And the median was 45.95.

XTER:T5O's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.53
* Ranked among companies with meaningful Days Payable only.

bioXXmed AG's Days Payable stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

bioXXmed AG Days Payable Historical Data

The historical data trend for bioXXmed AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioXXmed AG Days Payable Chart

bioXXmed AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

56.52

35.38

bioXXmed AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial															122.93	-	-	-	-

Competitive Comparison of bioXXmed AG's Days Payable

For the Biotechnology subindustry, bioXXmed AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

bioXXmed AG's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's Days Payable distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's Days Payable falls into.

bioXXmed AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

bioXXmed AG's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.101	+	0.033)	/	2 )	/	0	*	365
=	0.067					/	0	*	365
=	N/A

bioXXmed AG's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.033	+	0.048)	/	2 )	/	0	*	365 / 2
=	0.0405					/	0	*	365 / 2
=	N/A

bioXXmed AG Days Payable Related Terms

Thank you for viewing the detailed overview of bioXXmed AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

bioXXmed AG (XTER:T5O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bioXXmed AG (XTER:T5O) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

T5O:Germany T5O:Germany

Address

Riedstrasse 2, Darmstadt, HE, DEU, 64295

Website

https://www.bioxxmed.ag

bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.

bioXXmed AG (XTER:T5O) Headlines

No Headlines